Studies have reported that broadly neutralizing antibodies (Abs) have immense potential as antiviral therapeutic agents due to their capability to identify highly conserved epitopes seldom mutated in ...
No significant financial relationships to disclose. This is an ASCO Meeting Abstract from the 2007 ASCO Annual Meeting. This abstract does not include a full text component.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback